DAVID P SOUTHWELL

CIK 1251553 · Chief Executive Officer · last filed 2026-08-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.61M

Companies

10

Total Filings

83

Lifetime Open-Market Net

-$10.15M

Filer Profile

Reported Address
C/O INOTEK PHARMACEUTICALS CORPORATION
91 HARTWELL AVENUE
LEXINGTON, MA 02421
Related Filers
SEPRACOR INC /DE/ — 24 joint filings, latest 2007-09-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RCKT Director 317,646 $3.35 $1.06M -$1.46M 9 2026-08-05
PTCT Director 22,500 $66.06 $1.49M -$4.61M 22 2026-01-06
RCKTW Director 144,784 $0.00 $290 -$1.95M 5 2025-07-18
TCRX Chief Executive Officer 171,569 $0.32 $55.0K $185.9K 6 2023-02-06
SPRO Director $1.13 $0 2 2018-06-06
ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted President and CEO 15,691 $105.0K 4 2017-01-24
HUMAN GENOME SCIENCES INC (HGSI) Delisted Chief Financial Officer 0 $52.3K 10 2012-08-01
First Eagle Alternative Capital BDC, Inc. (TCRD) Delisted Director 38,500 $493.6K 6 2010-12-07
BIOSPHERE MEDICAL INC (BSMD) Delisted Director 0 $0 5 2010-09-10
SEPRACOR INC /DE/ (SEPR) Delisted Chief Financial Officer 143,728 -$2.97M 9 2007-09-12

Recent Filings · Page 3 of 9

83 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-02-06 TCRX Grant (A) $0 EDGAR
2023-01-09 PTCT Grant (A) +4,000 $0 EDGAR
2022-07-27 TCRX Grant (A) $0 EDGAR
2022-06-15 RCKT Grant (A) $0 EDGAR
2022-05-20 TCRX Buy (P) +25,000 $89.8K EDGAR
2022-01-20 TCRX Grant (A) $0 EDGAR
2022-01-11 PTCT Grant (A) +3,200 $0 EDGAR
2021-12-27 TCRX Exer (M) +48,670 $95.9K EDGAR
2021-09-09 TCRX Buy (P) +11,000 $96.1K EDGAR
2021-06-16 RCKT Grant (A) $0 EDGAR
Showing 2130 of 83
Page 3 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.